[PDF] Top 20 Original Article Changes of circulating ghrelin and obestatin levels in obese patients with or without type 2 diabetes mellitus

... and obestatin (Figure 1) were signifi- cantly higher in obese patients with Type 2 Diabetes Mellitus as compared to obese patients without Type ... See full document

... and changes in total fat mass [2, 19, 20], although a few have evaluat- ed local fat distribution by using magnetic re- sonance images of hepatic adipose tissue or ultrasound images of fat thickness [17, ... See full document

... in obese sub- jects, elevated leptin levels are not sufficient to prevent body weight increase and dysregula- tion of energy balance, suggesting that obese people are leptin resistant ...diabetic ... See full document

... Type 2 diabetes mellitus (T2DM) is a common non-communicable ...Most patients diagnosed with T2DM show signs of various cardiovascular and cerebrovascular diseases, such as coronary ... See full document

... 980 type 2 diabetes mellitus (T2DM) patients, 1017 hyperuricemia (HUA) and 1185 healthy controls were included in this ...HDL-C levels (P<0.001) were observed in female HUA. ... See full document

... to obese and healthy group but serum insulin and HOMA-IR was maximumin obese ...of type 2 diabetes which may be due to reason that patients were already on treatment of ... See full document

... 1. Increased intracellular glucose leads to the formation of advanced glycosylation end products (AGE's) via non enzymatic glycosylation of cellular proteins, AGE's have been shown to cross link. Proteins, accelerate ... See full document

... of Diabetes Mellitus include specific genetic defects in insulin secretion or action, metabolic abnormalities that impair insulin secretion, and a host of conditions that impair glucose ...onset ... See full document

... of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in ...Plasma ghrelin levels and hunger scores in humans initiating meals ... See full document

... among patients with ...in patients with DM and ...in patients with HCV, as compared to control patients (without HCV) with and without normal liver ... See full document

... These pharmacokinetic and pharmacodynamic differences partly explain the different dose frequency and a daily therapeutic dose of DPP- IV inhibitors. Except that vildagliptin should be given twice daily with the dose of ... See full document

... and circulating inhibitors of calcification suggesting that decreased expression or activity of these mediators (Osteocalcin) may also contribute to pathological cardiovascular ... See full document

... We have further evaluated aberrant methyla- tion status of CpG units that may be used as novel biomarkers for T2DM. Previous studies suggest that quantitative cytosine methylation profiling can be used to identify ... See full document

... and changes in life after the ...eventual diabetes complica- tions?” or “Do you have any thoughts about changes in your life since your diagnosis of diabetes?” At the end of the interview the ... See full document

... of patients with inherited defects of homocysteine metab- olism found a significant increase in plasma glutathione peroxidase activity in those with hyperhomocysteinaemia ... See full document

... efficacy levels were attained in decreasing blood glucose and HbA1c (%) in SQ and metformin ...diagnosed patients and blood glucose was poorly controlled by dietary exercise adjust- ments prior to ... See full document

... Efficacy and Tolerability of Dianex in Type 2 Diabetes Mellitus A Non Randomized, Open Label Non Comparative Study ORIGINAL ARTICLE Efficacy and Tolerability of Dianex in Type 2 Diabetes Mellitus A No[.] ... See full document

... the circulating insulin levels were even elevated to compensate for high blood glucose, and changes in SFRP5 levels induced by impaired β -cells have not been ...of patients diagnosed ... See full document

... 402 patients with T2DM, aged 20– 80 years old who referred to Yazd diabetic research ...(FPG), 2 hours post- prandial (2hpp), and HbA1c measured and compared during four ... See full document

... The deposition of fat in varying anatomic locations also has its own effect on morbidity. Among the distribution, intra-abdominal and abdominal subcutaneous fat is given a distinct importance. The determination of ... See full document